| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.05 |